Lemtrada causing ANCA-associated vasculitis adds to the growing number of autoimmune complications which can be regarded as Lemtrada side effects. Medical researchers in Switzerland recently presented the case of a 26-year-old man who developed life-threatening anti-neutrophil cytoplasmic autoantibody (ANCA) systemic vasculitis after being treated with Lemtrada (alemtuzumab) for relapsing-remitting multiple sclerosis.
This medical article about Lemtrada, “ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for multiple sclerosis”, was published February 21, 2020 by the Multiple Sclerosis Journal.
Anti-neutrophil cytoplasmic autoantibody (ANCA) vasculitis is an autoimmune disease that causes blood vessels to swell. Several types of ANCA vasculitis exist due to numerous causes, so patients diagnosed with ANCA vasculitis may display varied symptoms.
We will monitor the medical literature for possible other reports of Lemtrada causing ANCA-associated vasculitis as well as other more well-established Lemtrada side effects.[Read article in full at original source]